US Stock MarketDetailed Quotes

NVS Novartis AG

Watchlist
  • 106.610
  • +1.180+1.12%
Close Feb 18 16:00 ET
  • 109.000
  • +2.390+2.24%
Post 18:33 ET
210.56BMarket Cap18.16P/E (TTM)

About Novartis AG Company

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Company Profile

SymbolNVS
Company NameNovartis AG
Listing DateMay 11, 2000
Founded1996
CEODr. Vasant Narasimhan
MarketNYSE
Employees75883
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressLichtstrasse 35
CityBasel
ProvinceBasel-Stadt (Basle Town)
CountrySwitzerland
Zip Code4056
Phone41-61-324-11-11

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Vasant Narasimhan
  • Chief Executive Officer
  • 14.19M
  • Dr. Klaus Moosmayer, PhD
  • Chief Ethics, Risk and Compliance Officer
  • --
  • Dr. Aharon Gal, PhD
  • Chief Strategy and Growth Officer
  • --
  • Karen L. Hale
  • Chief Legal Officer
  • --
  • Dr. Shreeram Aradhye, M.D.
  • President, Development and Chief Medical Officer
  • --
  • Robert Kowalski
  • Chief People and Organization Officer
  • --
  • Harry Kirsch
  • Chief Financial Officer
  • 6.27M
  • Simon E Moroney, D.Phil.
  • Vice Chairman of the Board
  • 460.00K
  • Victor Bulto
  • President, US
  • 5.77M
  • Dr. Patrick Horber, M.D.
  • President, International
  • 5.89M
  • Dr. Steffen Lang, PhD
  • President, Operations
  • --
  • Joerg Reinhardt, PhD
  • Chairman of the Board
  • 3.80M
  • Dr. Fiona H. Marshall, PhD
  • President, Biomedical Research
  • --
  • Dr. Charles L. Sawyers
  • Independent Director
  • 360.00K
  • Ton Buechner
  • Independent Director
  • 424.68K
  • Daniel Hochstrasser
  • Independent Director
  • 394.68K
  • Bridgette P. Heller
  • Independent Director
  • 430.00K
  • John Douglas Young
  • Independent Director
  • 385.00K
  • Elizabeth Doherty
  • Independent Director
  • 450.00K
  • Dr. Nancy C. Andrews, M.D.,PhD
  • Independent Director
  • 360.00K
  • Frans Van Houten
  • Independent Director
  • 390.00K
  • Ana de Pro Gonzalo
  • Independent Director
  • 390.00K
  • William Thomas Winters
  • Independent Director
  • 360.00K
  • Patrice Bula
  • Lead Independent Director
  • 413.78K

Trending Stocks

Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More